Sun Pharmaceutical Industries
- Advice
- Hold
Start SIP in Sun Pharmaceutical Industries
Start SIPSun Pharmaceutical Industries Performance
Day Range
- Low 1,511
- High 1,546
52 Week Range
- Low 922
- High 1,639
- Open Price1,546
- Previous Close1,538
- Volume2176633
Sun Pharmaceutical Industries F&O
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 4,904 | 5,096 | 4,383 | 5,801 |
Operating Expenses Qtr Cr | 3,715 | 3,710 | 3,517 | 3,588 |
Operating Profit Qtr Cr | 1,359 | 1,386 | 949 | 2,361 |
Depreciation Qtr Cr | 400 | 393 | 415 | 412 |
Interest Qtr Cr | 215 | 194 | 158 | 161 |
Tax Qtr Cr | 30 | 18 | 9 | -9 |
Net Profit Qtr Cr | 721 | 889 | 381 | -1,021 |
Sun Pharmaceutical Industries Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 6
- Bearish Moving Average
- ___
- 10
- 20 Day
- ₹1,579.84
- 50 Day
- ₹1,536.10
- 100 Day
- ₹1,443.89
- 200 Day
- ₹1,316.61
- 20 Day
- ₹1,586.89
- 50 Day
- ₹1,560.33
- 100 Day
- ₹1,419.72
- 200 Day
- ₹1,271.57
Sun Pharmaceutical Industries Resistance and Support
Resistance | |
---|---|
First Resistance | 1,545.52 |
Second Resistance | 1,553.48 |
Third Resistance | 1,563.67 |
RSI | 39.01 |
MFI | 41.82 |
MACD Single Line | 14.84 |
MACD | 2.79 |
Support | |
---|---|
First Resistance | 1,527.37 |
Second Resistance | 1,517.18 |
Third Resistance | 1,509.22 |
Sun Pharmaceutical Industries Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 2,153,103 | 156,465,995 | 72.67 |
Week | 3,807,325 | 237,462,860 | 62.37 |
1 Month | 3,024,315 | 191,650,872 | 63.37 |
6 Month | 2,364,932 | 146,412,952 | 61.91 |
Sun Pharmaceutical Industries Result Highlights
Sun Pharmaceutical Industries Synopsis
NSE-Medical-Generic Drugs
Sun Pharma. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 20812.14 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2023. Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050.Market Cap | 369,389 |
Sales | 20,584 |
Shares in Float | 110.37 |
No of funds | 1059 |
Yield | 0.81 |
Book Value | 15.53 |
U/D Vol ratio | 1.4 |
LTDebt / Equity | 32 |
Alpha | 0.12 |
Beta | 0.49 |
Sun Pharmaceutical Industries
Owner Name | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|
Promoters | 54.48% | 54.48% | 54.48% |
Mutual Funds | 12.93% | 13.07% | 13.16% |
Insurance Companies | 5.02% | 5.06% | 5.12% |
Foreign Portfolio Investors | 17.08% | 16.78% | 16.48% |
Financial Institutions/ Banks | 0.04% | 0.06% | 0.08% |
Individual Investors | 5.41% | 5.55% | 5.65% |
Others | 5.04% | 5% | 5.03% |
Sun Pharmaceutical Industries Management
Name | Designation |
---|---|
Mr. Dilip S Shanghvi | Managing Director |
Mr. Sailesh T Desai | Whole Time Director |
Mr. Sudhir V Valia | Non Exe.Non Ind.Director |
Dr. Pawan Goenka | Independent Director |
Mr. Rama Bijapurkar | Independent Director |
Mr. Gautam Doshi | Independent Director |
Mr. Aalok D Shanghvi | Whole Time Director |
Mr. Sanjay Asher | Independent Director |
Mr. Rolf Hoffmann | Independent Director |
Sun Pharmaceutical Industries Forecast
Price Estimates
Sun Pharmaceutical Industries Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-01-31 | Quarterly Results & Interim Dividend | |
2023-11-01 | Quarterly Results | |
2023-08-03 | Quarterly Results | |
2023-05-26 | Audited Results & Final Dividend | |
2023-01-31 | Quarterly Results & Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2024-02-09 | INTERIM | Rs.8.50 per share(850%)Interim Dividend |
2023-07-28 | FINAL | Rs.4.00 per share(400%)Final Dividend |
2023-02-08 | INTERIM | Rs.7.50 per share(750%)Interim Dividend |
2022-08-22 | FINAL | Rs.3.00 per share(300%)Final Dividend |
2022-02-10 | INTERIM | Rs.7.00 per share(700%)Interim Dividend |
Sun Pharmaceutical Industries FAQs
What is Share Price of Sun Pharmaceutical Industries ?
Sun Pharmaceutical Industries share price is ₹1,519 As on 18 April, 2024 | 14:19
What is the Market Cap of Sun Pharmaceutical Industries ?
The Market Cap of Sun Pharmaceutical Industries is ₹364650.9 Cr As on 18 April, 2024 | 14:19
What is the P/E ratio of Sun Pharmaceutical Industries ?
The P/E ratio of Sun Pharmaceutical Industries is 40.9 As on 18 April, 2024 | 14:19
What is the PB ratio of Sun Pharmaceutical Industries ?
The PB ratio of Sun Pharmaceutical Industries is 6.1 As on 18 April, 2024 | 14:19
What is the future of Sun Pharmaceutical Industries (Sun Pharma)?
Sun Pharmaceutical Industries (Sun Pharma) has an operating revenue of INR 36,704.43 Cr. on a trailing 12-month basis. Annual revenue growth of 3% is not great, Pre-tax margin of 8% is okay. Institutional holding has gone up in the last reported quarter is a positive sign. Analyst Recommendation on Sun Pharmaceutical Industries (Sun Pharma): HOLD
Who is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma)?
Dilip Shanghvi is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma).
What is the ROE of Sun Pharmaceutical Industries (Sun Pharma)?
The ROE of Sun Pharmaceutical Industries (Sun Pharma) is 6% which is fair but needs improvement.
Is Sun Pharmaceutical Industries (Sun Pharma) Debt to Equity Ratio?
Sun Pharmaceutical Industries (Sun Pharma) has a reasonable debt to equity of 2%, which signals a healthy balance sheet.
What is the PE ratio of Sun Pharmaceutical Industries (Sun Pharma)?
The PE ratio of Sun Pharmaceutical Industries (Sun Pharma) is 81.5.